Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 1,962.50p on 11-06-2026 at 18:25:10
Change 41.00p 2.13%
Buy 1,962.00p
Sell 1,960.50p
Last Trade: Unknown 80,000.00 at 1,937.00p
Day's Volume: 7,722,952
Last Close: 1,962.50p
Open: 1,914.00p
ISIN: GB00BN7SWP63
Day's Range 1,910.50p - 1,973.00p
52wk Range: 1,315.00p - 2,282.00p
Market Capitalisation: £78.67b
VWAP: 1,950.02301p
Shares in Issue: 4.01b

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 80,000 1,937.00p Negotiated Trade
OTC Trade
18:17:53 - 11-Jun-26
Sell* 10,004 1,962.50p SI Trade
Suspected SELL Trade
17:23:06 - 11-Jun-26
Sell* 480 1,962.50p SI Trade
Suspected SELL Trade
17:23:06 - 11-Jun-26
Sell* 298 1,962.50p SI Trade
Suspected SELL Trade
17:23:06 - 11-Jun-26
Sell* 52 1,962.50p SI Trade
Suspected SELL Trade
17:23:05 - 11-Jun-26
Sell* 258 1,962.50p SI Trade
Suspected SELL Trade
17:23:05 - 11-Jun-26
Sell* 133 1,962.50p SI Trade
Suspected SELL Trade
17:23:05 - 11-Jun-26
Sell* 27 1,962.50p SI Trade
Suspected SELL Trade
17:23:02 - 11-Jun-26
Sell* 725 1,962.50p SI Trade
Suspected SELL Trade
17:23:02 - 11-Jun-26
Sell* 2,984 1,962.50p SI Trade
Suspected SELL Trade
17:22:45 - 11-Jun-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
11th Jun 2026 (Thu) 1,914.00 1,973.00 1,910.50 1,962.50 7,722,952
10th Jun 2026 (Wed) 1,915.50 1,929.00 1,890.50 1,921.50 6,411,067
9th Jun 2026 (Tue) 1,888.00 1,912.00 1,839.00 1,903.50 9,721,895
8th Jun 2026 (Mon) 1,936.50 1,942.50 1,904.50 1,913.00 4,169,869
5th Jun 2026 (Fri) 1,915.50 1,940.00 1,908.00 1,938.00 6,350,731
4th Jun 2026 (Thu) 1,859.50 1,904.00 1,859.00 1,902.00 12,974,263
3rd Jun 2026 (Wed) 1,817.50 1,856.50 1,813.00 1,851.50 8,183,347
2nd Jun 2026 (Tue) 1,840.00 1,842.00 1,805.00 1,820.50 6,580,750
1st Jun 2026 (Mon) 1,866.00 1,882.00 1,832.50 1,842.50 4,511,279
29th May 2026 (Fri) 1,919.50 1,920.50 1,881.50 1,881.50 20,433,488
28th May 2026 (Thu) 1,921.50 1,935.50 1,905.50 1,918.00 6,885,741
27th May 2026 (Wed) 1,893.50 1,943.00 1,893.50 1,939.50 5,898,532
26th May 2026 (Tue) 1,931.50 1,942.50 1,900.00 1,925.00 5,172,404
25th May 2026 (Mon) 1,915.00 1,915.00 1,915.00 1,915.00 0
22nd May 2026 (Fri) 1,925.00 1,927.50 1,906.00 1,915.00 5,933,421
21st May 2026 (Thu) 1,894.00 1,919.00 1,882.00 1,914.50 3,471,573
20th May 2026 (Wed) 1,900.00 1,914.50 1,885.50 1,898.50 4,657,565
19th May 2026 (Tue) 1,879.00 1,909.00 1,872.00 1,902.00 4,650,637
18th May 2026 (Mon) 1,855.50 1,883.00 1,846.00 1,876.50 3,354,365
15th May 2026 (Fri) 1,880.00 1,899.50 1,855.50 1,862.50 11,581,712
14th May 2026 (Thu) 1,872.50 1,890.00 1,868.50 1,872.50 4,263,561
13th May 2026 (Wed) 1,886.00 1,897.00 1,864.00 1,886.00 5,075,380
12th May 2026 (Tue) 1,822.50 1,891.50 1,822.00 1,891.50 12,114,945
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
11th Jun 2026 3:30 pm RNS Director/PDMR Shareholding
10th Jun 2026 3:30 pm RNS Director/PDMR Shareholding
9th Jun 2026 5:51 pm RNS Dr Hal Barron – New Directorship
9th Jun 2026 7:00 am RNS GSK enters agreement to acquire Nuvalent, Inc.
8th Jun 2026 3:00 pm RNS Transaction in Own Shares
1st Jun 2026 3:00 pm RNS Total Voting Rights
1st Jun 2026 3:00 pm RNS Transaction in Own Shares
28th May 2026 9:30 am RNS Positive Phase 3 data for bepirovirsen
27th May 2026 3:30 pm RNS Director/PDMR Shareholding
26th May 2026 3:00 pm RNS Admission to Trading
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

LONDON MARKET MIDDAY: FTSE 100 lags Europe as oil majors, GSK weigh

9th Jun 2026 12:10

(Alliance News) - Stock prices in London were mixed at midday on Tuesday, as the FTSE 100 lagged European peers despite renewed optimism for a peace deal in the Middle East, as oil majors and GSK weighed on the blue-chip index. Read More

WINNERS & LOSERS: GSK falls after Nuvalent buy; Molten Ventures jumps

9th Jun 2026 10:34

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday. Read More

LONDON MARKET OPEN: FTSE 100 down as GSK buys US drugmaker Nuvalent

9th Jun 2026 09:09

(Alliance News) - Stock prices in London opened mixed on Tuesday, as the FTSE 100 fell after GSK agreed to buy US-based cancer drug developer Nuvalent for USD10.6 billion. Read More

UPDATE: GSK buys cancer drug developer Nuvalent for USD10.6 billion

9th Jun 2026 09:00

(Alliance News) - GSK PLC on Tuesday said it has agreed to US-based cancer drug developer Nuvalent Inc for USD10.6 billion. Read More

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent

9th Jun 2026 07:58

(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Bellway reports an "increasingly challenging" housing market. Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,303.88
Change49.07

Login to your account

Forgot Password?

Not Registered